Changes

no edit summary
Line 25: Line 25:  
#Meet the criteria of any category of classifiable MDSs, but has 1% blasts detected at least two times in the peripheral blood.
 
#Meet the criteria of any category of classifiable MDSs, but has 1% blasts detected at least two times in the peripheral blood.
 
#Meet the criteria of MDS with single lineage dysplasia, MDS with ring sideroblasts and single lineage dysplasia, and MDS with isolated del(5q), but has pancytopenia (cytopenias are defined as haemoglobin concentration < 10 g/dL, platelet count < 100 x 10<sup>9</sup>/L, and absolute neutrophil count < 1.8 x 10<sup>9</sup> /L).
 
#Meet the criteria of MDS with single lineage dysplasia, MDS with ring sideroblasts and single lineage dysplasia, and MDS with isolated del(5q), but has pancytopenia (cytopenias are defined as haemoglobin concentration < 10 g/dL, platelet count < 100 x 10<sup>9</sup>/L, and absolute neutrophil count < 1.8 x 10<sup>9</sup> /L).
#Persistent cytopenia with < 2% blasts in the blood and <5% in the bone marrow, has [[Myelodysplastic Syndromes (MDS)|MDS-defining abnormality]] [link to MDS cytogenetic table] but no significant dysplasia in any myeloid lineage.
+
#Persistent cytopenia with < 2% blasts in the blood and <5% in the bone marrow, has [[HAEM4:Myelodysplastic Syndromes (MDS)|MDS-defining abnormality]] [link to MDS cytogenetic table] but no significant dysplasia in any myeloid lineage.
    
However, these cases may be evolved into a specific subtype of MDS and hence need to be reclassified then.
 
However, these cases may be evolved into a specific subtype of MDS and hence need to be reclassified then.